Skip to Content

Infliximab (Remicade®) Infusion

Infliximab (Remicade®) is a drug used for the treatment of Crohn's disease, ulcerative colitis, rheumatoid arthritis and other autoimmune conditions.

What to Tell Your Doctor Before Receiving an Infliximab (Remicade®) Infusion Treatment

Before Remicade® infusion therapy, notify your doctor if you had or are currently affected by any of the following:

  • Tuberculosis (TB) or have been around someone with TB
  • Recurring infections or immune system complications
  • Diabetes
  • Hepatitis B
  • Cancer or are at a heightened risk for cancer development
  • Any nervous system disorder, such as MS, Alzheimer's Disease, Parkinson's Disease, epilepsy, among others.

How to Prepare for Infliximab (Remicade®) Infusion Therapy

  • Expect for the Remicade® infusion to take two to three hours. Due to the length of the treatment, plan to bring reading or other quiet activities with you for your comfort.
  • Dress comfortably.
  • Confirm that you have had a Tuberculosis (TB) test within a year or since any travel outside of the United States or high-risk areas.

What to Expect Once You Arrive for Infliximab (Remicade®) Infusion Therapy

  • An accurate weight will be obtained to calculate a correct dose.
  • Your vital signs will be monitored frequently during the Remicade® treatment session, to watch for allergic reaction. Symptoms of allergic reaction may include: hives, difficulty breathing, high or low blood pressure.
  • An intravenous line will be inserted.

Note: Preparation of the drug occurs once the pharmacy has confirmed that the patient is present and the accurate weight is obtained. This may result in a slight delay.

For More Information

Infliximab (Remicade®) infusion therapy is available at all four hospital GI lab locations. For more information or to schedule an appointment with one of our gastroenterologists, please call 888.364.6400.

NorthShore offers interpretive language services for non-English speaking patients. A request for this no-cost service should be made at the time of appointment scheduling.